DNA Synthesizer Market Led by Biotech Companies

The DNA synthesizer market was valued at USD 266.3 million in 2023, which will reach USD 686.1 million by 2030, rising at a rate of 14.6% by the end of this decade. This is attributed to the rising occurrence of chronic diseases, growing requirement for more-personalized therapies, expanding acceptance of gene therapy, and growing investments in R&D.

Recently, there has been a drastic increase in the prevalence of severe chronic ailments, for example immunological ailments, cancer, and genetic illnesses, all over the globe.

Nearly 50,000 congenital disorders that are an outcome of a mutation of a single gene are recognized by scientists. This is powering the acceptance of gene therapy, as it can cure severe ailments that were previously untreatable, and the outcomes are better than expected. For example, numerous people have already regained their vision with the help of gene therapy, after suffering from hereditary, gradual blindness.

Based on end user, biotech companies led the industry, with a share of 50%, in 2023. This is due to the growing biotech-related research, powered by the increasing requirement for biologic drugs, for example vaccines.

Essentially, the increasing incidence of chronic ailments has powered regional administrations to spend on life science projects so that scientists can do more-efficient treatment, substantial investments but also tech progressions, which has boosted the count of novel therapeutics becoming obtainable to patients at a global level. 

It is because of the increasing acceptance of gene therapy all over the world, the demand for DNA synthesizer is on the rise. This trend will also continue in the years to come as well.

Read More

North America Is Dominating Bone Densitometer Industry

The value of the bone densitometer market stood at USD 316.6 million in 2023, and this number is projected to reach USD 441.3 million by 2030, advancing at a CAGR of 4.7% during the projection period.

This can be mainly credited to the growing occurrence of kidney illnesses, the increasing count of people having Vitamin D deficit, the rising occurrence of knee osteoarthritis, and the rising consciousness about linked issues and their treatment.

In 2023, the axial bone densitometer category dominated the market with a share of 65%. This is mainly because it offers better accuracy, the count of osteoporotic patients is increasing, and central dual-energy X-ray absorptiometry is extensively utilized because of its ease of use and security for both adults and children.

On the basis of application, the osteoporosis & osteopenia diagnosis category grips the largest market share. This can be credited to the increasing cases of bone-linked problems and the growing awareness regarding these problems.

The growing knowledge among people regarding the impacts of osteoporosis and its treatment is driving the development of the industry. Numerous government and private associations are concentrating on the rising understanding of osteopenia via numerous events and programs.

For example, the International Osteoporosis Foundation is an association devoted to health and knowledge linked to it. The organization offers data about the risk factors, treatments, and prevention substitutes to spread awareness regarding the disease among patients and physicians.

In terms of the bone densitometer market, North America holds the dominant position and will continue to do so for the next few years with a value of USD 0.17 billion by 2023. The presence of leading players, an extensive network of hospitals and healthcare establishments as well as the training of doctors are reasons for this.

Read More

Dermatology Devices Industry is Boosted by the Increasing Prevalence of Skin Diseases

The total size of the dermatology devices market was USD 7,117.4 million in 2023, and it will grow at a compound annual growth rate of 12.9% by the end of this decade, to touch a value of USD 16,552.7 million by 2030. 

This is because of the growing incidence of skin ailments all over the world, rising consciousness of aesthetic procedures, mounting healthcare spending in emerging nations, and dermatology devices letting dermatologists and surgeons to identify and treat numerous skin ailments in time.

There is a notable surge in the incidence of skin ailments at a global level recently, particularly amongst people living in regions with higher ozone exhaustion. The most common conditions are eczema, acne vulgarism, urticaria, sunburn, herpes zoster, and rosacea, contributing to the increasing acceptance of dermatology devices.

The imaging devices category will grow at a rate of 13.3% in the years to come. This is because of the growing requirement for diagnostic devices as a result of the increasing incidence of various skin disorders and skin cancer.

In 2023, North America led the industry with a share, of 55%, in the industry. This is because of the increasing incidence of skin ailments, the growing consciousness with regards to aesthetic cosmetic surgeries, the existence of leading players, the growing healthcare spending of the government, and easy availability of cutting-edge technologies.

Furthermore, in the U.S., over the past half a decade, about 7,000 novel incidences of self-reported skin issues have taken place every year. Amongst these, roughly 53% of contact dermatitis cases were sensitized, and 60% were as a result of irritants. Consequently, the acceptance of cutting-edge dermatology diagnostics is on the rise, and, in turn, is boosting the industry development in the nation.

It is because of the rising prevalence of skin diseases all over the world, the demand for dermatology devices is on the rise. And, this trend will continue in the years to come as well.

Read More

North America Is Dominating Dental Contouring Industry

The value of the dental contouring market stood at USD 2,848.3 million in 2023, and this number is projected to reach USD 4,283.7 million by 2030, advancing at a CAGR of 6.1% during the projection period. 

This development of the market can be credited to the increasing awareness of aesthetics and the growing demand for high-accuracy equipment for numerous teeth and gum treatment. Because of the tooth problems, people become unconfident about their smiles. The dental contouring process helps in advancing the symmetry of the teeth and eases their overlapping, by decreasing the amount of enamel existing on them, so they appear good.

In 2023, Diamond burs held the largest share, of 35%, this can be credited to their extreme hardness, due to this they can even grind enamel and allow faster and smoother cutting. Such devices are utilized when a high level of accuracy is needed during placing and shaping crowns, cutting via zirconia, and grinding porcelain.

The North American region has the dominating place in the dental contouring industry, and it will grip the same position during the projection period, with a value of USD 1.2 billion, credited to the fast acceptance of new and cutting-edge technologies in the continent. 

Furthermore, the increasing acceptance of such instruments and procedures, with the high expenditure power of people, is projected to fuel the industry in the continent. Also, the major players are concentrating on the growth of new items, acquisitions, mergers and collaborations, to attain a better position and greater consumer base.

Read More

Allergy Diagnostics Market is Led by North America

The allergy diagnostics market is estimated to reach USD 6,103.3 million in 2023, which will touch USD 12,814.2 million, with an 11.2% compound annual growth rate, by 2030.

The growth of this industry is because of the rising levels of environmental pollution, increasing investment to enhance allergy diagnostics by private & public administrations, and the occurrence of allergic disorders.

Furthermore, the inactive lifestyles, characterized by smoking, consumption of alcohol, and poor food habits; coupled with the high demand for in-vitro blood testing will further boost the industry expansion.

The consumables category, based on offering, is leading the industry in 2023, with a 45% share. This can be because consumables are an important component in detecting allergies.

North America is leading the industry in 2023, with a 55% share. This can be because of the strong healthcare system, swift technological developments in the medical sector, and advantageous reimbursement rules.

Additionally, the surging occurrence of allergies, coupled with the presence of inspiring procedures by associations to increase consciousness and make treatment and diagnosis available are also major contributors.

APAC will progress at the highest rate, of 11.5%, in the years to come. This can be primarily attributed to the requirement for less-invasive diagnostic technologies, speedily growing medical infrastructure, surging medical tourism activities, and unfulfilled clinical requirements.

With the rising levels of environmental pollution, the allergy diagnostics industry will continue to progress in the years to come.

Read More

Therapeutic Drug Monitoring Market Is Led by North America

The therapeutic drug monitoring market is estimated to generate USD 1,961.6 million in 2023, which will rise to USD 3,764.1 million, growing at a 9.8% compound annual growth rate, by 2030.

The growth of this industry is because of the rising need for genetic testing, developments in diagnostic technologies, enhancing healthcare infrastructure, and the mounting R&D expenses in healthcare.

Moreover, the industry is also boosted by the increasing product launches, the growing count of patients with chronic ailments, and the existence of helpful government regulatory guidelines and policies about the utilization of medication monitoring.

The immunoassays category, based on technology, is the largest contributor to the industry in 2023, with a 65% share, and it will remain the largest during this decade. This can be because of their high accessibility as well as rising usage in the discovery of medication analysis and development.

North America is leading the industry in 2023, with a 50% share, and it will remain leading throughout this decade. This can be because of the existence of key companies, along with the government auspicious rules that permit drug monitoring mainly in primary healthcare centers and private labs.

APAC is likely to propel at the fastest rate in the years to come. This is because of the large patient populace base, increasing customer expenditure, and rising per capita income in the region. 

The regional industry is also driven by the increasing economic advancement in APAC countries such as China, Japan, South Korea, and India.

With the surging need for genetic testing and enhancing healthcare infrastructure, the therapeutic drug monitoring industry will continue to progress in the coming years.

Read More

North America Is Dominating In-Situ Hybridization Industry

In 2023, the in-situ hybridization market amounted to USD 1,742.3 million and is set to grow at a compound annual growth rate of 12.8% between 2024 and 2030 reaching an estimated amount of USD 4,017.3 million by 2030.

This development of the market can be credited to the increasing acceptance of the in-situ hybridization (ISH) process for identifying numerous genetic illnesses and cancer, the rising pace of improvements in this method, and growing private and public funding for the research and development sector. Moreover, the rising demand for modified medicines is projected to fuel the industry growth.

There has been a distressing surge in cases of cancer worldwide in the past few years. This has caused a surge in the number of examined studies connected with this illness and those revolving around certain genomic irregularities, which are likely risk factors for numerous types of carcinomas.

In 2023, the FISH technology had a significant share, credited to the extensive variety of applications of this tech in diagnostics, like characterization with the aid of marker chromosomes, finding of numerical and structural chromosome flaws, finding of unusual and hereditary conditions, and drug abuse tracking.

In 2023, the North American region, generated the largest revenue share, of 55%, in the worldwide industry for in-situ hybridization solutions. The North American industry is projected to continue to uphold its dominating position during the projection period, mainly credited to the increasing count of autosomal diseases, cancer cases, genetic disorders, and also communicable conditions in the continent.

The U.S. is the key revenue generator in North America, mainly because of the strong government and private backing for the growth of new companion diagnostics methods.

Read More